News Focus
News Focus
icon url

DewDiligence

10/03/16 1:17 PM

#204873 RE: biopharm #204872

PPHM—A tenfold gain in the share price (what you posited) based on post-hoc biomarker data from a trial that was halted for futility would be an astonishing development. The colossal cash ball from outer space (#msg-125278503) is more likely, IMO.